# Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

> **NCT02432807** · PHASE3 · COMPLETED · sponsor: **Kurobe LLC** · enrollment: 303 (actual)

## Conditions studied

- Bacterial Conjunctivitis

## Interventions

- **DRUG:** Vancomycin 1.1%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02432807
- **Lead sponsor:** Kurobe LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-05-31
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432807, "Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02432807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*